IMEXA Powder for Oral Susp

Therapeutic Class

Macrolides Antibiotics


Imexa is indicated for infections caused by susceptible organisms; in lower respiratory tract infections including bronchitis and pneumonia, in skin and soft tissue infections, in otitis media and in upper respiratory tract infections including sinusitis and pharyngitis/tonsillitis. (Penicillin is the usual drug of choice in the treatment of Streptococcus pyogenes pharyngitis, including the prophylaxis of rheumatic fever. Azithromycin is generally effective in the eradication of streptococci from the oropharynx, however, data establishing the efficacy of azithromycin and the subsequent prevention of rheumatic fever are not available at present.) In sexually transmitted diseases in men and women, mexa is indicated in the treatment of uncomplicated genital infections due to Chlamydia trachomatis. It is also indicated in the treatment of uncomplicated genital infection due to non-multiresistant Neisseria gonorrhea, concurrent infection with Treponema pallidum should be excluded. Imexa is indicated, either alone or in combination with rifabutin, for prophylaxis against Mycobacterium avium = intracellulare complex (MAC) infection, an opportunistic infection prevalent in patients with advanced human immunodeficiency virus (HIV).

Chemical Composition

Imexa Powder for Oral Suspension: On reconstitution with water, each 5 ml of suspension contains Azithromycin Dihydrate equivalent to Azithromycin 200 mg


20 ml / Bot